• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

外周动脉疾病作为动脉粥样硬化疾病初始或后续表现患者的心血管结局:一项瑞典全国性研究的结果

Cardiovascular outcomes in patients with peripheral arterial disease as an initial or subsequent manifestation of atherosclerotic disease: Results from a Swedish nationwide study.

作者信息

Sigvant Birgitta, Hasvold Pål, Kragsterman Björn, Falkenberg Mårten, Johansson Saga, Thuresson Marcus, Nordanstig Joakim

机构信息

Department of Vascular Surgery, Karlstad Central Hospital, Karlstad, Sweden; Department of Clinical Science and Education, Södersjukhuset, Karolinska Institute, Stockholm, Sweden.

AstraZeneca Gothenburg, Mölndal, Sweden.

出版信息

J Vasc Surg. 2017 Aug;66(2):507-514.e1. doi: 10.1016/j.jvs.2017.01.067. Epub 2017 Apr 19.

DOI:10.1016/j.jvs.2017.01.067
PMID:28433332
Abstract

OBJECTIVE

Long-term progression of peripheral arterial disease (PAD) as initial manifestation of atherosclerotic arterial disease is not well described. Cardiovascular (CV) risk was examined in different PAD populations diagnosed in a hospital setting in Sweden.

METHODS

Data for this retrospective cohort study were retrieved by linking data on morbidity, medication use, and mortality from Swedish national registries. Primary CV outcome was a composite of myocardial infarction, ischemic stroke (IS), and CV death. Kaplan-Meier analysis and Cox proportional hazards modeling was used for describing risk and relative risk.

RESULTS

Of 66,189 patients with an incident PAD diagnosis (2006-2013), 40,136 had primary PAD, 16,786 had PAD + coronary heart disease (CHD), 5803 had PAD + IS, and 3464 had PAD + IS + CHD. One-year cumulative incidence rates of major CV events for the groups were 12%, 21%, 29%, and 34%, respectively. Corresponding numbers for 1-year all-cause death were 16%, 22%, 33%, and 35%. Compared with the primary PAD population, the relative risk increase for CV events was highest in patients with PAD + IS + CHD (hazard ratio [HR], 2.01), followed by PAD + IS (HR, 1.87) and PAD + CHD (HR, 1.42). Despite being younger, the primary PAD population was less intensively treated with secondary preventive drug therapy.

CONCLUSIONS

PAD as initial manifestation of atherosclerotic disease diagnosed in a hospital-based setting conferred a high risk: one in eight patients experienced a major CV event and one in six patients died within 1 year. Despite younger age and substantial risk of future major CV events, patients with primary PAD received less intensive secondary preventive drug therapy.

摘要

目的

外周动脉疾病(PAD)作为动脉粥样硬化性疾病的初始表现,其长期进展情况尚未得到充分描述。我们对瑞典一家医院确诊的不同PAD人群的心血管(CV)风险进行了研究。

方法

通过将瑞典国家登记处的发病率、用药情况和死亡率数据相链接,获取了这项回顾性队列研究的数据。主要CV结局是心肌梗死、缺血性中风(IS)和CV死亡的复合结局。采用Kaplan-Meier分析和Cox比例风险模型来描述风险和相对风险。

结果

在66189例首次诊断为PAD的患者(2006 - 2013年)中,40136例为原发性PAD,16786例为PAD + 冠心病(CHD),5803例为PAD + IS,3464例为PAD + IS + CHD。这些组的主要CV事件1年累积发生率分别为12%、21%、29%和34%。1年全因死亡的相应数字分别为16%、22%、33%和35%。与原发性PAD人群相比,PAD + IS + CHD患者发生CV事件的相对风险增加最高(风险比[HR],2.01),其次是PAD + IS(HR,1.87)和PAD + CHD(HR,1.42)。尽管原发性PAD人群年龄较轻,但接受二级预防药物治疗的强度较低。

结论

在医院环境中诊断为动脉粥样硬化疾病初始表现的PAD具有高风险:八分之一的患者发生了主要CV事件,六分之一的患者在1年内死亡。尽管年龄较轻且未来发生重大CV事件的风险很高,但原发性PAD患者接受的二级预防药物治疗强度较低。

相似文献

1
Cardiovascular outcomes in patients with peripheral arterial disease as an initial or subsequent manifestation of atherosclerotic disease: Results from a Swedish nationwide study.外周动脉疾病作为动脉粥样硬化疾病初始或后续表现患者的心血管结局:一项瑞典全国性研究的结果
J Vasc Surg. 2017 Aug;66(2):507-514.e1. doi: 10.1016/j.jvs.2017.01.067. Epub 2017 Apr 19.
2
Peripheral artery disease is a coronary heart disease risk equivalent among both men and women: results from a nationwide study.外周动脉疾病是男性和女性的冠心病等效风险:一项全国性研究的结果。
Eur J Prev Cardiol. 2015 Mar;22(3):317-25. doi: 10.1177/2047487313519344. Epub 2014 Jan 7.
3
Contemporary cardiovascular risk and secondary preventive drug treatment patterns in peripheral artery disease patients undergoing revascularization.接受血运重建的外周动脉疾病患者的当代心血管风险及二级预防药物治疗模式
J Vasc Surg. 2016 Oct;64(4):1009-1017.e3. doi: 10.1016/j.jvs.2016.03.429. Epub 2016 May 18.
4
Polyvascular disease and long-term cardiovascular outcomes in older patients with non-ST-segment-elevation myocardial infarction.老年非ST段抬高型心肌梗死患者的多血管疾病与长期心血管结局
Circ Cardiovasc Qual Outcomes. 2012 Jul 1;5(4):541-9. doi: 10.1161/CIRCOUTCOMES.111.964379. Epub 2012 Jun 19.
5
Myocardial infarction and peripheral arterial disease: Treatment patterns and long-term outcome in men and women results from a Swedish nationwide study.心肌梗死和外周动脉疾病:来自瑞典全国性研究的男性和女性的治疗模式和长期结局。
Eur J Prev Cardiol. 2021 Oct 25;28(13):1426-1434. doi: 10.1177/2047487319893046. Epub 2019 Dec 16.
6
Adverse outcomes in patients with atrial fibrillation and peripheral arterial disease: a report from the EURObservational research programme pilot survey on atrial fibrillation.心房颤动和外周动脉疾病患者的不良结局:来自 EURObservational 研究计划心房颤动试点调查的报告。
Europace. 2017 Sep 1;19(9):1439-1448. doi: 10.1093/europace/euw169.
7
Cardiovascular events in acute coronary syndrome patients with peripheral arterial disease treated with ticagrelor compared with clopidogrel: Data from the PLATO Trial.替格瑞洛与氯吡格雷治疗伴外周动脉疾病的急性冠脉综合征患者的心血管事件:来自 PLATO 试验的数据。
Eur J Prev Cardiol. 2015 Jun;22(6):734-42. doi: 10.1177/2047487314533215. Epub 2014 May 15.
8
Peripheral artery disease and outcomes after myocardial infarction: an individual-patient meta-analysis of 28,771 patients in CAPRICORN, EPEHESUS, OPTIMAAL and VALIANT.外周动脉疾病与心肌梗死后结局:CAPRICORN、EPEHESUS、OPTIMAL 和 VALIANT 研究 28771 例患者的个体患者荟萃分析。
Int J Cardiol. 2013 Sep 30;168(2):1094-101. doi: 10.1016/j.ijcard.2012.11.033. Epub 2012 Nov 26.
9
Ten Year Mortality in Different Peripheral Arterial Disease Stages: A Population Based Observational Study on Outcome.不同外周动脉疾病阶段的十年死亡率:基于人群的预后观察研究。
Eur J Vasc Endovasc Surg. 2018 Apr;55(4):529-536. doi: 10.1016/j.ejvs.2018.01.019. Epub 2018 Feb 23.
10
Geographic variation and risk factors for systemic and limb ischemic events in patients with symptomatic peripheral artery disease: Insights from the REACH Registry.有症状外周动脉疾病患者全身性和肢体缺血事件的地域差异及危险因素:来自REACH注册研究的见解
Clin Cardiol. 2017 Sep;40(9):710-718. doi: 10.1002/clc.22721. Epub 2017 May 18.

引用本文的文献

1
Comparison of efficacy and safety of sarpogrelate-based anti-platelet therapy with non-sarpogrelate-based anti-platelet therapy following arterial endovascular therapy: a systematic review.动脉血管内治疗后基于沙格雷酯的抗血小板治疗与非基于沙格雷酯的抗血小板治疗的疗效和安全性比较:一项系统评价
Ann Med Surg (Lond). 2024 Aug 22;86(10):6071-6078. doi: 10.1097/MS9.0000000000002373. eCollection 2024 Oct.
2
To Treat or not to Treat? The Fate of Patients with Intermittent Claudication Following Different Therapeutic Options.治疗还是不治疗?不同治疗方案下间歇性跛行患者的命运。
Rev Cardiovasc Med. 2024 Jun 24;25(6):229. doi: 10.31083/j.rcm2506229. eCollection 2024 Jun.
3
Lower All-Cause Mortality Risk in Females and Males with Peripheral Artery Disease following Pain-Free Home-Based Exercise: A 7-Year Observational Study.
无痛居家锻炼后外周动脉疾病女性和男性全因死亡风险降低:一项7年观察性研究
J Pers Med. 2023 Apr 5;13(4):636. doi: 10.3390/jpm13040636.
4
A multicenter, randomized, open-labelled, non-inferiority trial of sustained-release sarpogrelate versus clopidogrel after femoropopliteal artery intervention.多中心、随机、开放标签、非劣效性试验:股浅动脉介入治疗后缓释沙格雷酯与氯吡格雷的比较。
Sci Rep. 2023 Feb 13;13(1):2502. doi: 10.1038/s41598-023-29006-z.
5
A cross-sectional study on coronary artery disease diagnosis in patients with peripheral artery disease.一项关于外周动脉疾病患者冠状动脉疾病诊断的横断面研究。
J Interv Med. 2022 Oct 8;5(4):184-189. doi: 10.1016/j.jimed.2022.09.005. eCollection 2022 Nov.
6
A prospective community engagement initiative to improve clinical research participation in patients with peripheral artery disease.一项旨在提高外周动脉疾病患者临床研究参与度的前瞻性社区参与倡议。
SAGE Open Med. 2020 Jun 13;8:2050312120930915. doi: 10.1177/2050312120930915. eCollection 2020.
7
Eight-year outcome after invasive treatment of infrainguinal intermittent claudication: A population-based analysis from the Swedish vascular register (Swedvasc).股腘动脉间歇性跛行侵入性治疗后的八年结局:基于瑞典血管登记处(Swedvasc)的人群分析。
SAGE Open Med. 2020 May 24;8:2050312120926782. doi: 10.1177/2050312120926782. eCollection 2020.
8
Discordant Values in Lower Extremity Physiologic Studies Predict Increased Cardiovascular Risk.下肢生理研究中的不一致值预示着心血管风险增加。
J Am Heart Assoc. 2020 Jun 2;9(11):e015398. doi: 10.1161/JAHA.119.015398. Epub 2020 May 16.
9
Peripheral Arterial Disease and Its Associated Factors among Type 2 Diabetes Mellitus Patients at Debre Tabor General Hospital, Northwest Ethiopia.埃塞俄比亚西北部德布雷塔博尔综合医院 2 型糖尿病患者外周动脉疾病及其相关因素。
J Diabetes Res. 2020 Jan 29;2020:9419413. doi: 10.1155/2020/9419413. eCollection 2020.
10
Pathophysiology of chronic peripheral ischemia: new perspectives.慢性周围性缺血的病理生理学:新观点
Ther Adv Chronic Dis. 2020 Feb 5;11:2040622319894466. doi: 10.1177/2040622319894466. eCollection 2020.